United Kingdom local organizers:


The UK event will take place at the Liverpool University on the 2nd February from 4:30 PM to 7:30PM. 

University of Liverpool in London

33 Finsbury Square



United Kingdom

To register to the event, click here.

  • Prof. Khuloud Al-Jamal, Reader in Nanomedicine, Kings College London
  • Dr Dan Gooding, Co-founder of Nuformix
  • Prof. Andrew D. Miller, Director of KP Therapeutics & Professor at Kings College London
  • Dr. Jess Sutcliffe, Research Funding Manager at Cancer Research UK
  • Dr Euvian Tan, Expert at Nanomed TAB
  • Dr Gareth Wakefield, Chief Technical Officer at Xerion Healthcare
  • 16.30  Registration
  • 16.45  Welcome and Introduction to NWCD
  • 16.55  Examples of application of nanomedicine in cancer – Prof. Khuloud Al-Jamal, Kings College London
  • 17.15  The use of nanomedicine to enhance radiotherapy treatment of cancer – Dr Gareth Wakefield, Xerion Healthcare
  • 17.35  Pioneer Award: Funding revolutionary ideas, faster – Dr. Jess Sutcliffe, Cancer Research UK
  • 17.45 Accelerating the translation of nanomedicines – Dr Euvian Tan, Nanomed TAB
  • 17.50  Title TBC – Dr Dan Gooding, Nuformix
  • 18.10 Precision Nanomedicines; the best of all possible worlds? – Prof. Andrew D. Miller, KP Therapeutics & Kings College London
  • 18.30  Drinks Reception kindly sponsored by Precision Nanosystems

The press conference was well attended with more than 60 people as journalists and public. The exchanges were fruitful between the various speakers as entrepreneurs and researchers and the attendees.

A networking session followed the event, it added value to the afternoon and was well received by the attendees.

Media coverage

  • 1 article was issued on ecancer website